Search - tctmd.com

Displaying 61 - 74 of 74

Sort: Relevancy | Date

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

Presentation TCT 2012

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

Presenter: Dirk Sibbing

October 22, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

Presentation

Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI

Presenter: 56196|JY Kim

September 14, 2012

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

Presentation TCT 2012

Relationship between SYNTAX Score and Contrast Induced Acute Kidney Injury in Patients with CKD undergoing Coronary Angiography or PCI

Presenter: Ayesha C. Qureshi, Roshan Weerackody, Muhiddin Ozkor, Magdi Yaqoob, Akhil Kapur

January 03, 2012

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

News Daily News

Natriuretic Peptide Protects Kidney Function in CABG Patients with CKD

August 15, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

April 04, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

Advertisement

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

Relationship between SYNTAX Score and Contrast Induced Acute Kidney Injury in Patients with CKD undergoing Coronary Angiography or PCI

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

Natriuretic Peptide Protects Kidney Function in CABG Patients with CKD

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content